The forecast for transparency just turned cloudy. Key Messages Tucked into the latest opioid law are changes to the Sunshine Act. Beginning in 2022, drug and device companies now must report transfers of value to advance practice nurses and physician assistants. CMS also awarded a contract to analyze Open Payments data over the next five years. All drug and device should review both their Sunshine Act systems AND their reported…
The post Open Payments 2.0 – Big Changes Are Forecast appeared first on Whitelaw Compliance Group, LLC.